Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of Resveratrol and Resvega Versus Placebo on Incidence of Bilateralisation of Exudative AMD: a Double Masked Prospective Study.

NCT02625376 is registered in ClinicalTrials.gov with Poitiers University Hospital as lead sponsor.

NCT NCT02625376
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02625376 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of Resveratrol and Resvega Versus Placebo on Incidence of Bilateralisation of Exudative AMD: a Double Masked Prospective Study.
Lead sponsor
Poitiers University Hospital
Phase
Not applicable
Overall status
Terminated
Start date
August 6, 2015
Completion date
November 9, 2016
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration, amd, choroidal neovascularisation